EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis

Berna Kurt iD, Berna Ömür Çakmak Öksüzoğlu

Cancer Control · 2025

DOI: 10.1177/10732748251363323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Control, 2025. Verfasst von Berna Kurt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medical Nursing, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Cisplatin, Neoplasms, Antineoplastic Agents, Taste Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cisplatin is particularly recognized for its adverse effects, most notably its impact on chemosensory perception.

Methods

This cross-sectional study enrolled 98 cancer patients undergoing cisplatin therapy from April 2022 to December 2023. Patients were administered the Chemotherapy-Induced Taste Alteration Scale (CITAS) and the Rhodes Index of Nausea, Vomiting, and Retching (RINVR).

Results

A multiple linear regression model was employed to determine the effect of taste changes among cancer patients undergoing cisplatin therapy. The study of the model coefficients for the structural model (χ 2 /df = 1.338, P = .004, GFI = 0.955, CFI = 0.986, RMSEA = 0.063, SRMR = 0.079) demonstrated a robust match. This model, formed to evaluate the effects of taste alteration, appetite loss, nausea, vomiting, age, quality of life, and body surface area, was statistically significant and explained 76.4% of the variation. Multiple linear regression evaluations determined significant factors affecting taste alteration associated with nausea-vomiting [(95% CI: 0.111-0.244); P = 0.042], loss of appetite [(95% CI: 0.102-0.254); P = 0.000], age [(95% CI: −0.827-0.424); P = 0.001], quality of life [(95% CI: −0.908-0.489); P = 0.000], and body surface area [(95% CI: 0.024-0.098); P = 0.021].

Conclusion

Taste alteration significantly influenced symptoms of appetite loss, nausea, vomiting, age, and body surface area. These results provide valuable insights for developing effective intervention strategies to alleviate the relational effects of symptom clusters on patients’ quality of life and symptoms, particularly for cancer patients receiving cisplatin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinNeoplasmsAntineoplastic AgentsTaste DisordersHumansMaleFemaleCross-Sectional StudiesMiddle AgedQuality of LifeNauseaVomitingAgedAdultTaste

Stichwörter der Autor:innen

appetitechemotherapylinear regressionnauseataste alterationsvomiting

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Internal Medical Nursing, Hacettepe University, Ankara, Turkey.
  • Department of Internal Medical, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.

ORCID-Profile: Berna Kurt

Zitieren

APA

Kurt, B., & Öksüzoğlu, B. Ö. Ç. (2025). Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis. Cancer Control. https://doi.org/10.1177/10732748251363323

Vancouver

Kurt B, Öksüzoğlu BÖÇ. Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis. Cancer Control. 2025. doi:10.1177/10732748251363323

BibTeX
@article{Kurt2025,
  author = {Kurt, Berna and Öksüzoğlu, Berna Ömür Çakmak},
  title = {Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis},
  journal = {Cancer Control},
  year = {2025},
  doi = {10.1177/10732748251363323}
}
Kostenlos starten →